Usana Health Sciences (USNA) Non-Current Deferred Tax Liability (2011 - 2026)

Usana Health Sciences (USNA) has reported Non-Current Deferred Tax Liability for 16 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Non-Current Deferred Tax Liability rose 5.33% year-over-year to $5.1 million; the TTM figure through Apr 2026 stood at $5.1 million (up 5.33% YoY), while the FY2026 annual figure was $4.9 million, up 20.11% from the prior year.
• Non-Current Deferred Tax Liability rose to $5.1 million in Q2 2026 per USNA's latest filing, from $4.9 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $32.5 million in Q4 2022 and bottomed at $4.1 million in Q4 2024.
• Historically, Non-Current Deferred Tax Liability has averaged $8.3 million across 5 years, with a median of $4.8 million in 2022.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability surged 333.92% — and 2024, when it sank 86.73%.
• Usana Health Sciences' Non-Current Deferred Tax Liability stood at $32.5 million in 2022, then decreased by 5.66% to $30.7 million in 2023, then tumbled by 86.73% to $4.1 million in 2024, then rose by 9.67% to $4.5 million in 2025, then gained by 13.21% to $5.1 million in 2026.
• Business Quant data shows USNA's Non-Current Deferred Tax Liability at $5.1 million in Q2 2026, $4.9 million in Q1 2026, and $4.5 million in Q3 2025.